Correlation Between IL-10 Gene Expression and HPV Infection in Cervical Cancer: A Mechanism for Immune Response Escape

REFERENCES

• Parking D. M., Bray F., Ferlay J., Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Bornstein J. Human papillomavirus vaccine: the beginning of the end for cervical cancer. Isr Me Assoc J 2007; 9: 156–158
   PubMed Web of Science ®Google Scholar
• Mougin C., Dalstein V., Pretet J. L., Gay C., Schaal J. P., Riethmuller D. Epidemiology of cervical papillomavirus infections. Recent knowledge. Presse Med 2001; 30: 1017–1023
   PubMed Web of Science ®Google Scholar
• Ishiji T. Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 2000; 27: 73–86
   PubMedGoogle Scholar
• Mougin C., Dalstein V. Natural history of papillomavirus infections. Rev Prat 2006; 56: 1883–1889
   PubMedGoogle Scholar
• Sheu B. C., Chang W. C., Lin H. H., Chow S. N., Huang S. C. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia. J Obstet Gynaecol Res 2007; 33(2)103–113
   PubMed Web of Science ®Google Scholar
• Engelmark M. T., Ivansson E. L., Magnusson J. J., Gustavsson I. M., Beskow A. H., Magnusson P. K., Gyllensten U. B. Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs. Hum Mol Genet 2000; 15: 3351–3360
   Google Scholar
• Konya J., Dillner J. Immunity to oncogenic human papillomaviruses. Adv Cancer Res 2001; 82: 205–238
   PubMed Web of Science ®Google Scholar
• Goncalves M. A., Donadi E. A. Immune cellular response to HPV: current concepts. Braz J Infect Dis 2004; 8: 1–9
   PubMedGoogle Scholar
• Mota F., Rayment N., Chong S., Singer A., Chain B. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol 1999; 16: 33–40
   Google Scholar
• Giannini S. L., Hubert P., Doyen J., Boniver J., Delvenne P. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer 2002; 97: 654–659
   PubMed Web of Science ®Google Scholar
• Bermúdez V. H., Peralta O., Madrid-Marina V. Gene therapy with cytokines against cervical cancer. Salud Publica Mex 2005; 47: 458–468
   PubMed Web of Science ®Google Scholar
• Ibrahim R., Frederickson H., Parr A., Ward Y., Moncur J., Khleif S. N. Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism. Cancer 2006; 106: 1065–1077
   PubMed Web of Science ®Google Scholar
• Alcocer-Gonzalez J. M., Berumen J., Tamez-Guerra R., Bermudez-Morales V., Peralta-Zaragoza O., Hernandez-Pando R., Moreno J., Gariglio P., Madrid-Marina V. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 2006; 19: 481–491
   PubMed Web of Science ®Google Scholar
• Azar K. K., Tani M., Yasuda H., Sakai A., Inoue M., Sasagawa T. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 2004; 35: 1376–1384
   PubMed Web of Science ®Google Scholar
• El-Sherif A. M., Seth R., Tighe P. J., Jenkins D. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 2001; 195: 179–185
   PubMed Web of Science ®Google Scholar
• Sharma A., Rajappa M., Saxena A., Sharma M. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007; 17: 879–885
   PubMed Web of Science ®Google Scholar
• Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M. L., Stefanon B., Venzon D. J., Shearer G. M., de Clerici E. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997; 89: 245–250
   PubMed Web of Science ®Google Scholar
• Bais A. G., Beckmann I., Lindemans J., Ewing P. C., Meijer C. J., Snijders P. J., Helmerhorst T. J. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol 2005; 58: 1096–1010
   PubMed Web of Science ®Google Scholar
• Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu Rev Immunol 1993; 11: 165–190
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J. E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expresión. J Exp Med 1991; 74: 915–924
   Google Scholar
• Ding L., Linsley P. S., Huang L. Y., Germain R. N., Shevach E. M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224–1234
   PubMed Web of Science ®Google Scholar
• Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue simples. Biotechniques 1993; 15: 532–534; 536–537
   PubMed Web of Science ®Google Scholar
• Yoshikawa H., Kawana T., Kitagawa K., Mizuno M., Yoshikura H., Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991; 82: 524–531
   Google Scholar
• Hernádez-Giron C., Smith J. S., Lorincz A., Lazcano E., Hernandez-Avila M., Salmeron J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis 2005; 32: 613–618
   PubMed Web of Science ®Google Scholar
• Lazcano-Ponce E., Herrero R., Munoz N., Cruz A., Shah K. V., Alonso P., Hernandez P., Salmeron J., Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 412–420
   PubMed Web of Science ®Google Scholar
• Chen Q., Daniel V., Maher D. W., Hersey P. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 1994; 56: 755–760
   PubMed Web of Science ®Google Scholar
• Gastl G. A., Abrams J. S., Nanus D. M., Oosterkamp R., Silver J., Liu F., Chen M., Albino A. P., Bander N. H. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993; 55: 96–101
   PubMed Web of Science ®Google Scholar
• Huang M., Wang J., Lee P., Sharma S., Mao J. T., Meissner H. K., Modlin R., Wollman J., Dubinett S. M. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995; 55: 3847–3853
   PubMed Web of Science ®Google Scholar
• Brewer G., Saccani S., Sarkar S., Lewis A., Pestka S. Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. J Interferon Cytokine Res 2003; 23: 553–564
   PubMed Web of Science ®Google Scholar
• Sato T., McCue P., Masuoka K., Salwen S., Lattime E. C., Mastrangelo M. J., Berd D. Interleukin 10 production by human melanoma. Clin Cancer Res 1996; 2: 1383–1390
   PubMed Web of Science ®Google Scholar
• Gentile G., Formelli G., Orsoni G., Rinaldi A. M., Busacchi P. Immunosuppression and human genital papillomavirus infection. Eur J Gynaecol Oncol 1991; 12: 79–81
   PubMedGoogle Scholar
• Jacobs N., Giannini S. L., Doyen J., Baptista A, Moutschen M, Boniver J, Delvenne P. Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol 1998; 111: 219–24
   PubMed Web of Science ®Google Scholar
• Giannini S. L., Al-Saleh W., Piron H., Jacobs N., Doyen J., Boniver J, Delvenne P. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol 1998; 113: 183–9
   PubMed Web of Science ®Google Scholar
• de Gruijl T. D., Bontkes H. J., van den Muysenberg A. J. C., van Oostveen J. W., Stukart M. J., Verheijen R. H. M., Wallboomers J. M. M., Scheper R. J. Differences in cytokine mRNA profiles between pre-malignant and malignant lesions of the uterine cervix. Eur J Cancer 1999; 35: 490–497
   PubMed Web of Science ®Google Scholar
• Sheu B. C., Lin R. H., Lien H. C., Ho H. N., Hsu S. M., Huang S. C. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 2001; 167: 2972–2978
   PubMed Web of Science ®Google Scholar
• Hazelbag S., Fleuren G. J., Baelde J. J., Schuuring E., Kenter G. G., Gorter A. Cytokine profile of cervical cancer cells. Gynecol Oncol 2001; 83: 235–43
   PubMed Web of Science ®Google Scholar
• Tindle R. W. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2002; 2: 59–65
   PubMed Web of Science ®Google Scholar
• Kobashashi A., Greenblatt R. M., Anastos K., Minkoff H., Massad L. S., Young M., Levine A. M., Darragh T. M., Weinberg V., Smith-McCune K. K. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Research 2004; 64: 6766–6774
   PubMed Web of Science ®Google Scholar
• Yoon B. S., Kim Y. T., Kim J. W., Kim S. H., Kim J. H., Kim S. W. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet 2007; 98(1)48–53
   PubMed Web of Science ®Google Scholar
• de Gruijl T. D., Bontkes H. J., van den Muysenberg A. J., van Oostveen J. W., Stukart M. J., Verheijen R. H., van der Vange N., Snijders P. J., Meijer C. J., Walboomers J. M., Scheper R. J. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer 1999; 35: 490–497
   PubMed Web of Science ®Google Scholar
• Castle P. E., Hildesheim A., Bowman F. P., Strickler H. D., Walker J. L., Pustilnik T., Edwards R. P., Crowley-Nowick P. A. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol 2002; 22: 23–27
   PubMed Web of Science ®Google Scholar
• Shino Y., Shirasawa H., Kinoshita T., Simizu B. Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complexes binding to the cyclic AMP response element. J Virol 1997; 71: 4310–4318
   PubMed Web of Science ®Google Scholar
• Phillips A. C., Vousden K. H. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein. TBP J Gen Virol 1997; 78: 905–909
   PubMed Web of Science ®Google Scholar
• Dey A., Atcha I. A., Bagchi S. HPV16 E6 Oncoprotein Stimulates the Transforming Growth Factor-β 1 Promoter in Fibroblasts through a Specific GC-Rich Sequence. Virol 1997; 228: 190–199
   PubMed Web of Science ®Google Scholar
• Morosov A., Phelps W. C., Raychaudhuri P. Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60. J Biol Chem 1994; 269: 18434–18440
   PubMed Web of Science ®Google Scholar
• Wang L. Y., Zeng Y., Pan Z. Z., Zhu Z. H. Detection of intracellular and extracellular cytokines of CD4+CD25+ regulatory T cells in gastric cancer patients. Ai Zheng 2007; 26: 270–273
   PubMedGoogle Scholar
• Loskog A., Ninalga C., Paul-Wetterberg G., de la Torre M., Malmstrom P. U., Totterman T. H. Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. J Urol 2007; 177: 353–358
   PubMed Web of Science ®Google Scholar
• Smith D. R., Kunkel S. L., Burdick M. D., Wilke C. A., Orringer M. B., Whyte R. I., Strieter R. M. Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 1994; 145: 18–25
   PubMedGoogle Scholar
• Wojciechowska-Lacka A., Matecka-Nowak M., Adamiak E., Lacki J. K., Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 1996; 46: 155–158
   Google Scholar
• Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W.; WO'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Zoodsma M., Nolte I. M., te Meerman G. J., de Vries E. G., van der Zee A. G. HLA genes and other candidate genes involved in susceptibility for (pre) neoplastic cervical disease. Int J Oncol 2005; 26: 769–784
   PubMed Web of Science ®Google Scholar
• Kanodia S., Fahey L. M., Kast W. M. Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 2007; 7: 79–89
   PubMed Web of Science ®Google Scholar
• Kube D., Platzer C., von Knethen A., Straub H., Bohlen H., Hafner M., Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1–7
   Google Scholar
• Peralta-Zaragoza O., Bermúdez-Morales V., Gutierrez-Xicotencatl L., Alcocer-Gonzalez J., Recillas-Targa F., Madrid-Marina V. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence. Viral Immunol 2006; 19: 468–480
   PubMed Web of Science ®Google Scholar